The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community

被引：9
|
作者：
Garibotto, Valentina [1 ,2 ]
Albert, Nathalie L. [3 ]
Barthel, Henryk [4 ]
van Berckel, Bart [5 ]
Boellaard, Ronald [5 ]
Brendel, Matthias [3 ,6 ,7 ]
Cecchin, Diego [8 ]
Ekmekcioglu, Ozgul [9 ]
van de Giessen, Elsmarieke [5 ]
Guedj, Eric [10 ]
Lammerstma, Adriaan A. [5 ,11 ]
Semah, Franck [12 ]
Traub-Weidinger, Tatjana [13 ]
Van Weehaeghe, Donatienne [14 ]
Morbelli, Silvia [15 ]
机构：
[1] Univ Hosp Geneva, Diagnost Dept, Nucl Med & Mol Div, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland
[2] Univ Geneva, NIMTLab, Fac Med, Geneva, Switzerland
[3] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, Dept Nucl Med, Munich, Germany
[4] Univ Hosp Leipzig, Dept Nucl Med, Leipzig, Germany
[5] Univ Amsterdam, Dept Radiol & Nucl Med, Med Centers, Locat VUMC, Amsterdam, Netherlands
[6] DZNE German Ctr Neurodegenerat Dis, Munich, Germany
[7] Univ Munich, SyNergy, Munich, Germany
[8] Univ Hosp Padua, Dept Med DIMED, Nucl Med Unit, Padua, Italy
[9] Univ Hlth Sci, Sisli Hamidiye Etfal Educ & Res Hosp, Dept Nucl Med, Istanbul, Turkey
[10] Aix Marseille Univ, Cent Marseille, Timone Hosp, APHM,Nucl Med Dept,Inst Fresnel,CNRS,CERIMED, Marseille, France
[11] Univ Groningen, Univ Med Ctr Groningen, Med Imaging Ctr, Dept Nucl Med & Mol Imaging, Groningen, Netherlands
[12] Univ Lille, CHU, Dept Nucl Med, Lille, France
[13] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Div Nucl Med, Vienna, Austria
[14] UZ Leuven, Nucl Med, Leuven, Belgium
[15] IRCCS Osped Policlin San Martino, Nucl Med Unit, Genoa, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / 10期
基金：
瑞士国家科学基金会;
关键词：
AMYLOID-PET; BIOMARKERS; DEMENTIA; TRIALS;
D O I：
10.1007/s00259-021-05485-y
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：3033 / 3036
页数：4
相关论文
共 50 条
  • [1] Disease-modifying treatment approaches for Alzheimer's disease
    Froelich, Lutz
    Hausner, Lucrezia
    NERVENARZT, 2021, 92 (12): : 1239 - 1248
  • [2] Novel disease-modifying therapeutics for the treatment of Alzheimer's disease
    Leger, Gabriel C.
    Massoud, Fadi
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (04) : 423 - 442
  • [3] Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's disease
    Dobson, Ruth
    Patterson, Katherine
    Malik, Reshad
    Mandal, Uttara
    Asif, Hina
    Humphreys, Ros
    Payne, Michael
    O-Charoenrat, Eng
    Huzzey, Lauren
    Clare, Adam
    Green, Kate
    Morton, Maija
    Sohrabi, Catrin
    Singh, Navreen
    Pasupathy, Amirtha
    Patel, Milan
    Whiteman, Sam
    Maxmin, Kate
    Bass, Nicholas
    Gupta, Bhavya
    Cooper, Claudia
    Marshall, Charles
    Weil, Rimona Sharon
    Mummery, Catherine J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (09) : 796 - 803
  • [4] Emerging amyloid disease-modifying drugs for Alzheimer's disease
    Galimberti, Daniela
    Scarpini, Elio
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (01) : 5 - 7
  • [5] Optimum Design of Disease-Modifying Trials on Alzheimer's Disease
    Xiong, Chengjie
    Luo, Jingqin
    Gao, Feng
    Chen, Ling
    Yan, Yan
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2012, 4 (03): : 216 - 227
  • [6] Defining and labeling disease-modifying treatments for Alzheimer's disease
    Cummings, Jeffrey L.
    ALZHEIMERS & DEMENTIA, 2009, 5 (05) : 406 - 418
  • [7] The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease
    Ritchie, Craig W.
    Russ, Tom C.
    Banerjee, Sube
    Barber, Bob
    Boaden, Andrew
    Fox, Nick C.
    Holmes, Clive
    Isaacs, Jeremy D.
    Leroi, Ira
    Lovestone, Simon
    Norton, Matt
    O'Brien, John
    Pearson, Jim
    Perry, Richard
    Pickett, James
    Waldman, Adam D.
    Wong, Wai Lup
    Rossor, Martin N.
    Burns, Alistair
    ALZHEIMERS RESEARCH & THERAPY, 2017, 9
  • [8] Advancements in Pharmacological Treatment of Alzheimer's Disease: The Advent of Disease-Modifying Therapies (DMTs)
    Wang, Qiong
    Chen, Sihui
    Wang, Junhui
    Shang, Huifang
    Chen, Xueping
    BRAIN SCIENCES, 2024, 14 (10)
  • [9] A Model Predicting Healthcare Capacity Gaps For Alzheimer's Disease-Modifying Treatment in Canada
    Black, Sandra E.
    Budd, Nathalie
    Nygaard, Haakon B.
    Verret, Louis
    Virdi, Shikha
    Watts, Laura Tamblyn
    Wilson, Melanie
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2024, 51 (04) : 487 - 494
  • [10] Immunotherapy for Parkinson's Disease and Alzheimer's Disease: A Promising Disease-Modifying Therapy
    Mahboob, Anns
    Ali, Hasan
    Alnaimi, Aljazi
    Yousef, Mahmoud
    Rob, Mlaak
    Al-Muhannadi, Nawaf Ahmad
    Senevirathne, Degiri Kalana Lasanga
    Chaari, Ali
    CELLS, 2024, 13 (18)
12345